Citrogene

ASC Therapeutics Inc, based in Milpitas, CA, is a biopharmaceutical company dedicated to discovering, developing, and delivering cures for intractable and rare diseases through innovative gene and cell therapies. Their proprietary gene editing platform, TARGATT, along with other advanced technologies, enables the company to focus on therapeutic products aimed at treating blood disorders. With a strong team of experienced scientists and industry veterans, ASC Therapeutics is committed to revolutionizing disease treatment by collaborating with leading academic and industry partners globally. Their current pipeline includes several preclinical and clinical stage programs targeting conditions such as hemophilia and thalassemia, reflecting their vision of providing groundbreaking and safe cures for patients. Generated from the website

Our mission at Thermo Fisher is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity.

EnColl Corporation, established in 1994 and based in Fremont, CA, specializes in the development, manufacture, and marketing of high-purity Type-I collagen-based products. Utilizing patented technology, the company produces collagen that is 99% pure, ensuring minimal immunogenicity and high bioactivity for various medical applications, including wound healing and tissue regeneration. One of EnColl's flagship products, Helicoll, serves as an acellular skin substitute designed to promote blood vessel regeneration and support cellular migration, making it a valuable tool in wound management. Committed to stringent quality control standards, EnColl's products cater to a wide range of biomedical applications and have demonstrated significant efficacy in clinical settings. Generated from the website